MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells

Life Sci. 2008 Feb 27;82(9-10):519-28. doi: 10.1016/j.lfs.2007.12.007. Epub 2007 Dec 17.

Abstract

Intestinal epithelial cells (IEC) have adapted to the presence of commensal bacteria through a state of tolerance that involves a limited response to lipopolysaccharide (LPS). Low or absent expression of two LPS receptor molecules, the myeloid differentiation (MD)-2 receptor, and toll-like receptor (TLR)4 was suggested to underlie LPS tolerance in IEC. In the present study we performed transfections of TLR4 and MD-2 alone or combined in different IEC lines derived from intestinal cancer (Caco-2, HT-29, and SW837). We found that LPS responsiveness increased more than 100-fold when IEC were transfected with MD-2 alone, but not TLR4. The release of interleukin (IL)-8, but also the expression of cyclooxygenase (Cox-)2 and the related secretion of prostaglandin (PG)E2 were coordinately stimulated by LPS in IEC transfected with MD-2 alone. Supernatants collected from MD-2-transfected IEC supported LPS activation of naïve HT-29, providing additional support to the concept that MD-2 alone endows IEC with LPS responsiveness. LPS responsiveness detected at concentrations as low as 110 pg/ml, and maximal values obtained by 10 ng/ml were clearly beyond those evoked by classical stimuli as IL-1beta. In polarized cells, apical LPS stimulation was markedly more efficient than basolateral. Our data contradict previous opinion that both TLR4 and MD-2 limit IEC response to LPS, and emphasize the prominent role of MD-2 in intestinal immune responses to Gram-negative bacteria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthracenes / pharmacology
  • Caco-2 Cells
  • Cell Line, Tumor
  • Cells, Cultured
  • Cyclooxygenase 2 / biosynthesis
  • Dinoprostone / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Flow Cytometry
  • Gene Expression
  • HT29 Cells
  • Humans
  • Imidazoles / pharmacology
  • Interleukin-8 / metabolism
  • Intestines / pathology
  • Lipopolysaccharides / pharmacology*
  • Lymphocyte Antigen 96 / genetics
  • Lymphocyte Antigen 96 / physiology*
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism
  • Monocytes / cytology
  • Monocytes / drug effects
  • Monocytes / metabolism
  • NF-kappa B / metabolism
  • Pyridines / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / physiology
  • Transfection

Substances

  • Anthracenes
  • Enzyme Inhibitors
  • Imidazoles
  • Interleukin-8
  • Lipopolysaccharides
  • Lymphocyte Antigen 96
  • NF-kappa B
  • Pyridines
  • RNA, Messenger
  • TLR4 protein, human
  • Toll-Like Receptor 4
  • pyrazolanthrone
  • Cyclooxygenase 2
  • Mitogen-Activated Protein Kinases
  • Dinoprostone
  • SB 203580